Tüdőrák: nyitott vizsgálatok itt: Dél-Korea

169 nyitott vizsgálatnak van helyszíne itt: Dél-Korea. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Kísérleti kezelés · 3. fázis · Bristol-Myers Squibb
Pusan National University Hospital, Busan · Chungbuk National University Hospital, Cheongju-si · Keimyung University Dongsan Hospital, Daegu · Kyungpook National University Chilgok Hospital, Deagu · National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Hwasun · Gachon University Gil Medical Center, Namdong-gu · CHA Bundang Medical Center, CHA University, Seongnam-si · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Korea University Guro Hospital, Seoul · Samsung Medical Center, Seoul · Pusan National University Yangsan Hospital, Yangsan
Regiszter frissítve: 2026-11-09
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
National Cancer Center (Site 2305), Goyang-si · Samsung Medical Center (Site 2304), Seoul · Seoul St. Mary's Hospital (Site 2307), Seoul · Seoul National University Hospital (Site 2303), Seoul · Severance Hospital Yonsei University Health System (Site 2302), Seoul · Ajou University Hospital (Site 2306), Suwon · The Catholic University of Korea St. Vincent s Hospital (Site 2301), Suwon
Regiszter frissítve: 2026-11-09
NCT07227597
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Kísérleti kezelés · 1/2. fázis · Merck Sharp & Dohme LLC
Asan Medical Center (Site 1404), Seoul · Samsung Medical Center (Site 1401), Seoul · Severance Hospital Yonsei University Health System (Site 1403), Seoul · Seoul National University Hospital (Site 1402), Seoul
Regiszter frissítve: 2026-11-09
NCT07486817
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Kísérleti kezelés · 2. fázis · Boehringer Ingelheim
Severance hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul
Regiszter frissítve: 2026-11-09
NCT07513376
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
Chungbuk National University Hospital (Site 5201), Cheongju-si · National Cancer Center (Site 5202), Goyang-si · Seoul National University Bundang Hospital (Site 5200), Seongnam-si · Severance Hospital, Yonsei University Health System (Site 5204), Seoul · Samsung Medical Center (Site 5206), Seoul · Asan Medical Center (Site 5205), Seoul · The Catholic University Of Korea St. Vincent's Hospital (Site 5203), Suwon
Regiszter frissítve: 2026-11-09
NCT07541170
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Pusan National University Hospital, Busan · Kyungpook National University Chilgok Hospital, Daegu · Yeungnam University Medical Center, Daegu · Chungnam National University Hospital, Daejeon · Ajou University Medical Center, Gyeonggi-do · Gachon University Gil Medical Center, Incheon · Chonnam National University Hwasun Hospital, Jeollanam-do · Seoul National University Bundang Hospital, Seongnam-si · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul
Regiszter frissítve: 2026-11-09
NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Kísérleti kezelés · 1/2. fázis · Inhibrx Biosciences, Inc
Inje University College of Medicine, Busan · Chungbuk National University Hospital, Cheongju-si · The Catholic University of Korea St. Vincent's Hospital, Gyeonggi-do · Chonnam National University Hwasun Hospital, Hwasun · Gachon University Gil Medical Center, Incheon · CHA Bundang Medical Center, Seongnam-si · Hanyang University Seoul Hospital, Seoul · Korea University Anam Hospital, Seoul · Asan Medical Center, Seoul · Korea University Guro Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Ajou University Hospital, Suwon
Regiszter frissítve: 2026-11-06
NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Kísérleti kezelés · 1/2. fázis · Nuvalent Inc.
National Cancer Center, Goyang-si · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Regiszter frissítve: 2026-11-06
NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Kísérleti kezelés · 3. fázis · Amgen
Pusan National University Hospital, Busan · National Cancer Center, Goyang-si Gyeonggi-do · Gachon University Gil Medical Center, Incheon · Asan Medical Center, Seoul · Korea University Anam Hospital, Seoul · Samsung Medical Center, Seoul · Korea University Guro Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnam-do
Regiszter frissítve: 2026-11-06
NCT06881784
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Kísérleti kezelés · 3. fázis · Revolution Medicines, Inc.
Chungbuk National University Hospital, Cheongju-si · Ajou University Hospital, Gyeonggi-do · Chonnam National University Hwasun Hospital, Hwasun · Samsung Medical Center, Seoul · Korea University Anam Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Regiszter frissítve: 2026-11-06
NCT06983743
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Kísérleti kezelés · 1. fázis · Erasca, Inc.
Inje University Haeundae Paik Hospital Clinical Trial Center, Haeundae · Seoul St. Mary's Hospital Clinical Trial Center, Seoul
Regiszter frissítve: 2026-11-06
NCT07699328
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Kísérleti kezelés · 1/2. fázis · Voronoi, Inc
Chungbuk National University Hospital, Cheongju-si · Seoul National University Bundang Hospital, Seongnam-si · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon
Regiszter frissítve: 2026-11-06
NCT07921888
Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA
Kutatás · Eun Hye Lee
Gangnam Severance Hospital, Seoul · Severance hospital, Seoul · Yongin Severance Hospital, Yongin-si
Regiszter frissítve: 2026-11-06
NCT05789082
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Kísérleti kezelés · 1/2. fázis · Hoffmann-La Roche
Pusan National University Hospital, Busan · Korea University Guro Hospital, Seoul · Asan Medical Center, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Regiszter frissítve: 2026-11-05
NCT06586957
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Kísérleti kezelés · 1. fázis · NiKang Therapeutics, Inc.
Chung-Ang University Gwangmyeong Hospital, Gwangmyeong · Yonsei Cancer Center / Severance Hospital, Seoul
Regiszter frissítve: 2026-11-05
NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Kísérleti kezelés · 3. fázis · Hoffmann-La Roche
Pusan National University Hospital, Busan · Chungbuk National University Hospital, Cheongju-si · Kyungpook National University Chilgok Hospital, Daegu · Korea University Guro Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Hospital, Seoul
Regiszter frissítve: 2026-11-05
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Kísérleti kezelés · 3. fázis · Pfizer
Chungbuk National University Hospital, Cheongju-si · Boramae Medical Center, Dongjak-gu · National Cancer Center, Goyang-si · Inje University Haeundae Paik Hospital, Haeundae-gu · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam-si · Samsung Medical Center, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon
Regiszter frissítve: 2026-11-05
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Kísérleti kezelés · 3. fázis · Bristol-Myers Squibb
Chungbuk National University Hospital, Cheongju-si · Seoul National University Bundang Hospital, Seongnam · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul
Regiszter frissítve: 2026-11-05
NCT07519655
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Kísérleti kezelés · 1. fázis · Pfizer
Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Regiszter frissítve: 2026-11-05
NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Kísérleti kezelés · 1/2. fázis · Genmab
Korea Institute of Radiological and Medical Sciences, Seoul
Regiszter frissítve: 2026-11-04
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Kísérleti kezelés · 3. fázis · Eli Lilly and Company
Chungbuk National University Hospital, Cheongju-si · Keimyung University Dongsan Hospital, Daegu · Kyungpook National University Chilgok Hospital, Deagu · Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu · National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Hwasun · Severance Hospital, Yonsei University Health System, Seoul · Korea University Guro Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea Yeouido St. Mary's Hospital, Seoul · Korea University Anam Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon · Pusan National University Yangsan Hospital, Yangsan
Regiszter frissítve: 2026-11-04
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Kísérleti kezelés · 1. fázis · Eli Lilly and Company
National Cancer Center, Goyang-si Gyeonggi-do
Regiszter frissítve: 2026-11-04
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Kísérleti kezelés · 3. fázis · Bayer
Chungbuk National University Hospital | Hematology and Oncology, Chungcheongbuk-do · Chonnam National University Hwasun Hospital | Pulmonology and Critical Care Medicine, Hwasun-gun · Gyeongsang National University Hospital | Oncology, Jinju · Seoul National University Hospital | Oncology, Jongno -Gu · Samsung Medical Center | Oncology, Seoul · Severance Hospital | Oncology, Seoul · St Vincent's Hospital | Oncology, Suwon · Pusan National University Yangsan Hospital | Pulmonology, Yangsan
Regiszter frissítve: 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Kísérleti kezelés · 1. fázis · Eli Lilly and Company
Asan Medical Center, Seoul
Regiszter frissítve: 2026-11-04
NCT06561685
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Kísérleti kezelés · 1. fázis · Eli Lilly and Company
National Cancer Center, Ilsandong-gu · Severance Hospital, Yonsei University Health System, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon
Regiszter frissítve: 2026-11-04

Minden vizsgálat (Tüdőrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek